Organogenesis Holdings Inc. Quarterly Depreciation in USD from Q1 2018 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Organogenesis Holdings Inc. annual/quarterly Depreciation history and growth rate from Q1 2018 to Q1 2024.
  • Organogenesis Holdings Inc. Depreciation for the quarter ending March 31, 2024 was $3.07M, a 14% increase year-over-year.
  • Organogenesis Holdings Inc. Depreciation for the twelve months ending March 31, 2024 was $10.8M, a 50.5% increase year-over-year.
  • Organogenesis Holdings Inc. annual Depreciation for 2024 was $13.6M, a 30.4% increase from 2023.
  • Organogenesis Holdings Inc. annual Depreciation for 2023 was $10.4M, a 78.8% increase from 2022.
  • Organogenesis Holdings Inc. annual Depreciation for 2022 was $5.85M, a 1.11% increase from 2021.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $10.8M $3.07M +$378K +14% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $10.4M $2.98M +$1.47M +97% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-27
Q3 2023 $8.98M $2.54M +$1.09M +74.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $7.89M $2.23M +$700K +45.8% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $7.19M $2.69M +$1.35M +100% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $5.85M $1.51M -$257K -14.5% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-27
Q3 2022 $6.1M $1.46M -$481K -24.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $6.58M $1.53M +$465K +43.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $6.12M $1.35M +$337K +33.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $5.78M $1.77M +$261K +17.3% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $5.52M $1.94M +$802K +70.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $4.72M $1.06M +$172K +19.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $4.55M $1.01M +$108K +12% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $4.44M $1.51M +$280K +22.8% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 $4.16M $1.14M +$343K +43.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $3.82M $891K +$32K +3.73% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $3.78M $902K $0 0% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q4 2019 $3.78M $1.23M +$529K +75.5% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 $3.25M $792K -$69K -8.01% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $3.32M $859K -$16K -1.83% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $3.34M $902K +$30K +3.44% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $3.31M $701K Oct 1, 2018 Dec 31, 2018 10-K 2021-03-16
Q3 2018 $861K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $875K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $872K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.